Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
711401 | Eganelisib ( IPI-549 ) | 1693758-51-8 | ≧98.0% | |
Eganelisib (IPI-549) is a first-in-class, orally administered, highly selective PI3Kγ | ||||
24067 | PBT434 Hydrobromide | 1232841-78-9 | ≧98.0% | |
PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||
233141 | NXP-800 ( CCT361814 ) | 1693734-80-3 | ≧98.0% | |
NXP800 is an oral small molecule inhibitor of the Heat Shock Factor 1 (HSF1) pathway. | ||||
20313 | Cenerimod ( ACT-334441 ) | 1262414-04-9 | ≧98.0% | |
Cenerimod is a potent and orally active immunomodulator, exhibited EC50 value of 2.7 | ||||
822223 | Venglustat ( ibiglustat ) | 1401090-53-6 | ≧98.0% | |
Venglustat(ibiglustat)is an oral inhibitor of an enzyme called glucosylceramide synth | ||||
822224 | RP-5063(Brilaroxazine) | 1239729-06-6 | ≧98.0% | |
RP-5063(Brilaroxazine) is a multimodal modulator of serotonin and dopamine recept | ||||
822225 | Cadisegliatin (TTP-399) | 859525-02-3 | ≧98.0% | |
Cadisegliatin(TTP-399) is a potential liver-selective glucokinase (GK) activator for | ||||
51910 | TRV130 ( Oliceridine ) | 1401031-39-7 | ≧98.0% | |
TRV 130 Hcl is a novel -opioid receptor (MOR) G protein-biased ligand; elicits robust | ||||
191123 | Tafenoquine succinate | 106635-81-8 | ≧98.0% | |
Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
231106 | PDS-0330 | 2904682-19-3 | ≧98.0% | |
PDS0330 is a new claudin-1 inhibitor in Colorectal Cancer. | ||||
16122939 | Emeramide ( BDTH2 ) | 351994-94-0 | ≧98.0% | |
Emeramide, also known as BDTH2, is a mercury and heavy metal chelator. BDTH2 molecule | ||||
62502 | TG02 ( SB1317 ) | 937270-47-8 | ≧98.0% | |
SB1317 (TG02) is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. SB1317 was so |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1